Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis
17 páginas
- Autores:
-
Lechtig Wasserman, Sharon
Liebisch Rey, Hans
Diaz Pinilla, Nicolas
Blanco, Jhosep
Fuentes Barreiro, Yuli-Viviana
Bustos, Rosa Helena
- Tipo de recurso:
- Fecha de publicación:
- 2021
- Institución:
- Universidad de la Sabana
- Repositorio:
- Repositorio Universidad de la Sabana
- Idioma:
- eng
- OAI Identifier:
- oai:intellectum.unisabana.edu.co:10818/48222
- Acceso en línea:
- https://www.mdpi.com/2079-6382/10/2/177
http://hdl.handle.net/10818/48222
- Palabra clave:
- Critical illness
Septic shock
Sepsis
Carbapenems
Therapeutic drug monitoring;
Antibiotic treatment outcome
Antimicrobial drug resistance
Gram-negative bacteria
- Rights
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional
id |
REPOUSABA2_776a91726b95e28e4871bf3899356cf5 |
---|---|
oai_identifier_str |
oai:intellectum.unisabana.edu.co:10818/48222 |
network_acronym_str |
REPOUSABA2 |
network_name_str |
Repositorio Universidad de la Sabana |
repository_id_str |
|
spelling |
Lechtig Wasserman, SharonLiebisch Rey, HansDiaz Pinilla, NicolasBlanco, JhosepFuentes Barreiro, Yuli-VivianaBustos, Rosa Helena8/31/2021 11:362021-08-31T16:36:13Z2021-02-10Lechtig-Wasserman S., Liebisch-Rey H., Diaz-Pinilla N., Blanco J., Fuentes-Barreiro Y-V., Bustos R-H.* Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis. Antibiotics. 2021; 10(2):177. https://doi.org/10.3390/antibiotics10020177. ISSN 2079-63822079-6382https://www.mdpi.com/2079-6382/10/2/177http://hdl.handle.net/10818/4822210.3390/antibiotics1002017717 páginasDrug monitoring is one strategy of antibiotic stewardship to face antimicrobial resistance. This strategy could have a determinant role in critically ill patients treated with carbapenems to overcome pharmacokinetic variability, reduce the risk of subtherapeutic dosage or toxicity, and reduce the risks inherent to treatment. However, the effectiveness of therapeutic drug monitoring (TDM) is unknown. This paper aims to identify TDM effectiveness in critically ill patients treated with carbapenems. English and ClinicalTrials.gov databases were searched to identify relevant studies evaluating carbapenem TDM. Randomized controlled trials (RCTs) and comparative cohort studies were selected for inclusion if they compared carbapenem TDM to standard care in adult critically ill or sepsis/septic shock patients. The primary outcome was mortality. Secondary outcomes included morbidity, clinical cure, microbiological eradication, antimicrobial resistance, drug-related side effects, and achievement of target plasma concentrations. Overall, performing carbapenem TDM was not associated with a decrease in mortality. However, it could be evidence for a relationship with clinical cure as well as target attainment. Some studies found favorable outcomes related to clinical and microbiological responses, such as lower procalcitonin levels at the end of the monitored therapy compared to standard care. For the primary and secondary outcomes analyzed, strong evidence was not identified, which could be due to the size, risk of bias, and design of selected studies.application/pdfengAntibioticsAntibiotics. 2021; 10(2):177Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Universidad de La SabanaIntellectum Repositorio Universidad de La SabanaCritical illnessSeptic shockSepsisCarbapenemsTherapeutic drug monitoring;Antibiotic treatment outcomeAntimicrobial drug resistanceGram-negative bacteriaCarbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-AnalysisarticlepublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://intellectum.unisabana.edu.co/bitstream/10818/48222/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/48222/3/license.txtf52a2cfd4df262e08e9b300d62c85cabMD5310818/48222oai:intellectum.unisabana.edu.co:10818/482222023-02-27 09:18:52.692Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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 |
dc.title.es_CO.fl_str_mv |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
title |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
spellingShingle |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis Critical illness Septic shock Sepsis Carbapenems Therapeutic drug monitoring; Antibiotic treatment outcome Antimicrobial drug resistance Gram-negative bacteria |
title_short |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
title_full |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
title_fullStr |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
title_full_unstemmed |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
title_sort |
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis |
dc.creator.fl_str_mv |
Lechtig Wasserman, Sharon Liebisch Rey, Hans Diaz Pinilla, Nicolas Blanco, Jhosep Fuentes Barreiro, Yuli-Viviana Bustos, Rosa Helena |
dc.contributor.author.none.fl_str_mv |
Lechtig Wasserman, Sharon Liebisch Rey, Hans Diaz Pinilla, Nicolas Blanco, Jhosep Fuentes Barreiro, Yuli-Viviana Bustos, Rosa Helena |
dc.subject.other.en.fl_str_mv |
Critical illness Septic shock Sepsis Carbapenems Therapeutic drug monitoring; Antibiotic treatment outcome Antimicrobial drug resistance Gram-negative bacteria |
topic |
Critical illness Septic shock Sepsis Carbapenems Therapeutic drug monitoring; Antibiotic treatment outcome Antimicrobial drug resistance Gram-negative bacteria |
description |
17 páginas |
publishDate |
2021 |
dc.date.available.none.fl_str_mv |
2021-08-31T16:36:13Z |
dc.date.issued.none.fl_str_mv |
2021-02-10 |
dc.date.accessioned.none.fl_str_mv |
8/31/2021 11:36 |
dc.type.en.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.hasVersion.es_CO.fl_str_mv |
publishedVersion |
dc.identifier.citation.es_CO.fl_str_mv |
Lechtig-Wasserman S., Liebisch-Rey H., Diaz-Pinilla N., Blanco J., Fuentes-Barreiro Y-V., Bustos R-H.* Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis. Antibiotics. 2021; 10(2):177. https://doi.org/10.3390/antibiotics10020177. ISSN 2079-6382 |
dc.identifier.issn.none.fl_str_mv |
2079-6382 |
dc.identifier.other.none.fl_str_mv |
https://www.mdpi.com/2079-6382/10/2/177 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10818/48222 |
dc.identifier.doi.none.fl_str_mv |
10.3390/antibiotics10020177 |
identifier_str_mv |
Lechtig-Wasserman S., Liebisch-Rey H., Diaz-Pinilla N., Blanco J., Fuentes-Barreiro Y-V., Bustos R-H.* Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis. Antibiotics. 2021; 10(2):177. https://doi.org/10.3390/antibiotics10020177. ISSN 2079-6382 2079-6382 10.3390/antibiotics10020177 |
url |
https://www.mdpi.com/2079-6382/10/2/177 http://hdl.handle.net/10818/48222 |
dc.language.iso.es_CO.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.none.fl_str_mv |
Antibiotics. 2021; 10(2):177 |
dc.rights.*.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
dc.format.es_CO.fl_str_mv |
application/pdf |
dc.publisher.es_CO.fl_str_mv |
Antibiotics |
dc.source.es_CO.fl_str_mv |
Universidad de La Sabana Intellectum Repositorio Universidad de La Sabana |
institution |
Universidad de la Sabana |
bitstream.url.fl_str_mv |
https://intellectum.unisabana.edu.co/bitstream/10818/48222/2/license_rdf https://intellectum.unisabana.edu.co/bitstream/10818/48222/3/license.txt |
bitstream.checksum.fl_str_mv |
4460e5956bc1d1639be9ae6146a50347 f52a2cfd4df262e08e9b300d62c85cab |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Intellectum Universidad de la Sabana |
repository.mail.fl_str_mv |
contactointellectum@unisabana.edu.co |
_version_ |
1811952271473246208 |